Patent number 378301 has been granted to MERZ PHARMA GMBH & CO. KGAA that is titled PROCESS FOR PREPARING A HIGHLY PURE NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN AND USES THEREOF. The primary independent claim of this patent states a process for preparing a highly pure neurotoxic component of a botulinum toxin. The method includes cultivation of Clostridium Botulinum under conditions that allow production of a botulinum toxin. The patent applicant responded to this objection by stating that the claimed process does not pertain to mere forms/derivatives of known compounds. The applicant further submits that the examples provided in the filed specification show the enhanced efficacy of the claimed highly pure neurotoxic component. This patent falls under the category of Chemical. Overall, this patent covers a process for preparing a highly pure neurotoxic component of a botulinum toxin by cultivating Clostridium botulinum under conditions that allow production of a botulinum toxin, and isolating the neurotoxic component from the botulinum toxin.